The Cost-Effectiveness of Three Prevention Strategies in Alzheimer’s Disease: Results from the Multidomain Alzheimer Preventive Trial (MAPT)
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2426-0266
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
The Cost-Effectiveness of Three Prevention Strategies in Alzheimer’s Disease: Results from the Multidomain Alzheimer Preventive Trial (MAPT) ; volume:8 ; number:4 ; day:2 ; month:8 ; year:2021 ; pages:425-435 ; date:10.2021
The journal of prevention of Alzheimer's disease ; 8, Heft 4 (2.8.2021), 425-435, 10.2021
- Creator
-
Costa, Nadège
Mounié, M.
Pagès, A.
Derumeaux, H.
Rapp, T.
Guyonnet, S.
Coley, N.
Cantet, C.
Carrié, I.
Andrieu, S.
Molinier, L.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.14283/jpad.2021.47
- URN
-
urn:nbn:de:101:1-2022010719101506300895
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:21 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Costa, Nadège
- Mounié, M.
- Pagès, A.
- Derumeaux, H.
- Rapp, T.
- Guyonnet, S.
- Coley, N.
- Cantet, C.
- Carrié, I.
- Andrieu, S.
- Molinier, L.
- SpringerLink (Online service)
Other Objects (12)
Cost-effectiveness of cerebrospinal biomarkers for the diagnosis of Alzheimer’s disease
Alzheimer’s Disease
Alzheimer’s disease: targeting the glutamatergic system
The neuropathological diagnosis of Alzheimer’s disease
The endotoxin hypothesis of Alzheimer’s disease
Alzheimer’s disease: targeting the peripheral circulation
The neuroimmune axis of Alzheimer’s disease
Predicting the course of Alzheimer’s progression
The plasma peptides of Alzheimer’s disease
The Alzheimer’s disease drug development landscape
Nutrition guidance within a multimodal intervention improves diet quality in prodromal Alzheimer’s disease: Multimodal Preventive Trial for Alzheimer’s Disease (MIND-ADmini)
A proposed preventive role for Gamma-hydroxybutyrate (XyremR) in Alzheimer’s disease
Cost-effectiveness of cerebrospinal biomarkers for the diagnosis of Alzheimer’s disease
Alzheimer’s Disease
Alzheimer’s disease: targeting the glutamatergic system
The neuropathological diagnosis of Alzheimer’s disease
The endotoxin hypothesis of Alzheimer’s disease
Alzheimer’s disease: targeting the peripheral circulation
The neuroimmune axis of Alzheimer’s disease
Predicting the course of Alzheimer’s progression
The plasma peptides of Alzheimer’s disease
The Alzheimer’s disease drug development landscape
Nutrition guidance within a multimodal intervention improves diet quality in prodromal Alzheimer’s disease: Multimodal Preventive Trial for Alzheimer’s Disease (MIND-ADmini)
A proposed preventive role for Gamma-hydroxybutyrate (XyremR) in Alzheimer’s disease
Cost-effectiveness of cerebrospinal biomarkers for the diagnosis of Alzheimer’s disease
Alzheimer’s Disease
Alzheimer’s disease: targeting the glutamatergic system
The neuropathological diagnosis of Alzheimer’s disease
The endotoxin hypothesis of Alzheimer’s disease
Alzheimer’s disease: targeting the peripheral circulation
The neuroimmune axis of Alzheimer’s disease
Predicting the course of Alzheimer’s progression
The plasma peptides of Alzheimer’s disease
The Alzheimer’s disease drug development landscape
Nutrition guidance within a multimodal intervention improves diet quality in prodromal Alzheimer’s disease: Multimodal Preventive Trial for Alzheimer’s Disease (MIND-ADmini)